EU5 Orthobiologics Market Outlook to 2033 – Cartilage Repair, Bone Grafts and Substitutes, Bone Growth Stimulators, Soft Tissue Biologics and Viscosupplementation

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$5995
Buy Report

Published: April 27, 2026 Report Code: GDME21840CRDB-ST

Select Item

GlobalData’s “EU5 Orthobiologics Outlook to 2033” is a comprehensive databook report, covering key market data on the EU5 Orthobiologics market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Cartilage Repair, Bone Grafts and Substitutes, Bone Growth Stimulators, Soft Tissue Biologics and Viscosupplementation

The EU5 Orthobiologics Market report provides key information and data on:
• Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
• 2025 company share data for Orthobiologics Market.
• Global corporate-level profiles of key companies operating within the EU5 Orthobiologics Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

EU5 Orthobiologics is segmented as follows:

• Cartilage Repair

• Bone Grafts and Substitutes

• Bone Growth Stimulators

• Soft Tissue Biologics

• Viscosupplementation

Reasons to Buy

The EU5 Orthobiologics Market report helps you to develop:

• Business strategies by identifying the key market segments poised for strong growth in the future.

• Market-entry and market expansion strategies.

• Design competition strategies by identifying who-stands-where in the market.

• Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

• Understand the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Medtronic Plc
Sanofi
Enovis Corp
Fidia farmaceutici SpA
Stryker Corp
Arthrex Inc
Zimmer Biomet Holdings Inc
Orthofix Holdings Inc
Smith & Nephew Plc
Bioventus Inc
DePuy Synthes Inc
Orthofix Medical Inc
LifeNet Health Inc
Ferring Pharmaceuticals AS
Highridge Inc
Globus Medical Inc
AlloSource
Anika Therapeutics Inc
CONMED Corp
Xtant Medical Holdings Inc
Avanos Medical Inc

Table of Contents

1 Table of Contents

1.1 List of Tables

1.2 List of Figures

2 Introduction

2.1 What Is This Report About?

2.2 Orthobiologics Market Segmentation

2.3 Definitions of Markets Covered in the Report

3 Orthobiologics Market, EU5

3.1 Orthobiologics Market, EU5, Revenue ($m), 2018-2033

3.2 Orthobiologics Market, EU5, Revenue ($m), 2018-2033

3.3 Orthobiologics Market, EU5, Volume (Units), 2018-2033

3.4 Orthobiologics Market, EU5, Volume (Units), 2018-2033

3.5 Orthobiologics Market, EU5, Company Share by Revenue ($m), 2025

4 Orthobiologics Market, France

4.1 Orthobiologics Market, France, Revenue ($m), 2018-2033

4.1.1 Bone Grafts and Substitutes Market, France, Revenue ($m), by Segment, 2018-2033

4.1.2 Bone Growth Stimulators Market, France, Revenue ($m), by Segment, 2018-2033

4.1.3 Cartilage Repair Market, France, Revenue ($m), by Segment, 2018-2033

4.1.4 Soft Tissue Biologics Market, France, Revenue ($m), by Segment, 2018-2033

4.1.5 Viscosupplementation Market, France, Revenue ($m), by Segment, 2018-2033

4.2 Orthobiologics Market, France, Volume (Units), 2018-2033

4.2.1 Bone Grafts and Substitutes Market, France, Volume (Units), by Segment, 2018-2033

4.2.2 Bone Growth Stimulators Market, France, Volume (Units), by Segment, 2018-2033

4.2.3 Cartilage Repair Market, France, Volume (Units), by Segment, 2018-2033

4.2.4 Soft Tissue Biologics Market, France, Volume (Units), by Segment, 2018-2033

4.2.5 Viscosupplementation Market, France, Volume (Units), by Segment, 2018-2033

4.3 Orthobiologics Market, France, Average Price ($), 2018-2033

4.4 Orthobiologics Market, France, Company Share by Revenue ($m), 2025

5 Orthobiologics Market, Germany

5.1 Orthobiologics Market, Germany, Revenue ($m), 2018-2033

5.1.1 Bone Grafts and Substitutes Market, Germany, Revenue ($m), by Segment, 2018-2033

5.1.2 Bone Growth Stimulators Market, Germany, Revenue ($m), by Segment, 2018-2033

5.1.3 Cartilage Repair Market, Germany, Revenue ($m), by Segment, 2018-2033

5.1.4 Soft Tissue Biologics Market, Germany, Revenue ($m), by Segment, 2018-2033

5.1.5 Viscosupplementation Market, Germany, Revenue ($m), by Segment, 2018-2033

5.2 Orthobiologics Market, Germany, Volume (Units), 2018-2033

5.2.1 Bone Grafts and Substitutes Market, Germany, Volume (Units), by Segment, 2018-2033

5.2.2 Bone Growth Stimulators Market, Germany, Volume (Units), by Segment, 2018-2033

5.2.3 Cartilage Repair Market, Germany, Volume (Units), by Segment, 2018-2033

5.2.4 Soft Tissue Biologics Market, Germany, Volume (Units), by Segment, 2018-2033

5.2.5 Viscosupplementation Market, Germany, Volume (Units), by Segment, 2018-2033

5.3 Orthobiologics Market, Germany, Average Price ($), 2018-2033

5.4 Orthobiologics Market, Germany, Company Share by Revenue ($m), 2025

6 Orthobiologics Market, Italy

6.1 Orthobiologics Market, Italy, Revenue ($m), 2018-2033

6.1.1 Bone Grafts and Substitutes Market, Italy, Revenue ($m), by Segment, 2018-2033

6.1.2 Bone Growth Stimulators Market, Italy, Revenue ($m), by Segment, 2018-2033

6.1.3 Cartilage Repair Market, Italy, Revenue ($m), by Segment, 2018-2033

6.1.4 Soft Tissue Biologics Market, Italy, Revenue ($m), by Segment, 2018-2033

6.1.5 Viscosupplementation Market, Italy, Revenue ($m), by Segment, 2018-2033

6.2 Orthobiologics Market, Italy, Volume (Units), 2018-2033

6.2.1 Bone Grafts and Substitutes Market, Italy, Volume (Units), by Segment, 2018-2033

6.2.2 Bone Growth Stimulators Market, Italy, Volume (Units), by Segment, 2018-2033

6.2.3 Cartilage Repair Market, Italy, Volume (Units), by Segment, 2018-2033

6.2.4 Soft Tissue Biologics Market, Italy, Volume (Units), by Segment, 2018-2033

6.2.5 Viscosupplementation Market, Italy, Volume (Units), by Segment, 2018-2033

6.3 Orthobiologics Market, Italy, Average Price ($), 2018-2033

6.4 Orthobiologics Market, Italy, Company Share by Revenue ($m), 2025

7 Orthobiologics Market, Spain

7.1 Orthobiologics Market, Spain, Revenue ($m), 2018-2033

7.1.1 Bone Grafts and Substitutes Market, Spain, Revenue ($m), by Segment, 2018-2033

7.1.2 Bone Growth Stimulators Market, Spain, Revenue ($m), by Segment, 2018-2033

7.1.3 Cartilage Repair Market, Spain, Revenue ($m), by Segment, 2018-2033

7.1.4 Soft Tissue Biologics Market, Spain, Revenue ($m), by Segment, 2018-2033

7.1.5 Viscosupplementation Market, Spain, Revenue ($m), by Segment, 2018-2033

7.2 Orthobiologics Market, Spain, Volume (Units), 2018-2033

7.2.1 Bone Grafts and Substitutes Market, Spain, Volume (Units), by Segment, 2018-2033

7.2.2 Bone Growth Stimulators Market, Spain, Volume (Units), by Segment, 2018-2033

7.2.3 Cartilage Repair Market, Spain, Volume (Units), by Segment, 2018-2033

7.2.4 Soft Tissue Biologics Market, Spain, Volume (Units), by Segment, 2018-2033

7.2.5 Viscosupplementation Market, Spain, Volume (Units), by Segment, 2018-2033

7.3 Orthobiologics Market, Spain, Average Price ($), 2018-2033

7.4 Orthobiologics Market, Spain, Company Share by Revenue ($m), 2025

8 Orthobiologics Market, United Kingdom

8.1 Orthobiologics Market, United Kingdom, Revenue ($m), 2018-2033

8.1.1 Bone Grafts and Substitutes Market, United Kingdom, Revenue ($m), by Segment, 2018-2033

8.1.2 Bone Growth Stimulators Market, United Kingdom, Revenue ($m), by Segment, 2018-2033

8.1.3 Cartilage Repair Market, United Kingdom, Revenue ($m), by Segment, 2018-2033

8.1.4 Soft Tissue Biologics Market, United Kingdom, Revenue ($m), by Segment, 2018-2033

8.1.5 Viscosupplementation Market, United Kingdom, Revenue ($m), by Segment, 2018-2033

8.2 Orthobiologics Market, United Kingdom, Volume (Units), 2018-2033

8.2.1 Bone Grafts and Substitutes Market, United Kingdom, Volume (Units), by Segment, 2018-2033

8.2.2 Bone Growth Stimulators Market, United Kingdom, Volume (Units), by Segment, 2018-2033

8.2.3 Cartilage Repair Market, United Kingdom, Volume (Units), by Segment, 2018-2033

8.2.4 Soft Tissue Biologics Market, United Kingdom, Volume (Units), by Segment, 2018-2033

8.2.5 Viscosupplementation Market, United Kingdom, Volume (Units), by Segment, 2018-2033

8.3 Orthobiologics Market, United Kingdom, Average Price ($), 2018-2033

8.4 Orthobiologics Market, United Kingdom, Company Share by Revenue ($m), 2025

9 Overview of Key Companies in EU5 Orthobiologics Market

9.1 Medtronic Plc

9.1.1 Company Overview

9.2 Sanofi

9.2.1 Company Overview

9.3 Enovis Corp

9.3.1 Company Overview

9.4 Fidia farmaceutici SpA

9.4.1 Company Overview

9.5 Stryker Corp

9.5.1 Company Overview

9.6 Arthrex Inc

9.6.1 Company Overview

9.7 Zimmer Biomet Holdings Inc

9.7.1 Company Overview

9.8 Orthofix Holdings Inc

9.8.1 Company Overview

9.9 Smith & Nephew Plc

9.9.1 Company Overview

9.10 Bioventus Inc

9.10.1 Company Overview

9.11 DePuy Synthes Inc

9.11.1 Company Overview

9.12 Orthofix Medical Inc

9.12.1 Company Overview

9.13 LifeNet Health Inc

9.13.1 Company Overview

9.14 Ferring Pharmaceuticals AS

9.14.1 Company Overview

9.15 Highridge Inc

9.15.1 Company Overview

9.16 Globus Medical Inc

9.16.1 Company Overview

9.17 AlloSource

9.17.1 Company Overview

9.18 Anika Therapeutics Inc

9.18.1 Company Overview

9.19 CONMED Corp

9.19.1 Company Overview

9.20 Xtant Medical Holdings Inc

9.20.1 Company Overview

9.21 Avanos Medical Inc

9.21.1 Company Overview

10 Orthobiologics Market Pipeline Products

11 Recent Developments

11.1 Corporate Communications

11.1.1 Nov 21, 2025: Surgeons Collaborate to Treat War Injuries in Ukraine

11.1.2 Nov 19, 2025: LEM Surgical Completes First U.S. Clinical Procedures

11.1.3 Nov 15, 2025: [COA2025] Aikang Medical Excels on Day Two with Six Events Highlighting Global Orthopedic Expertise

11.1.4 Nov 14, 2025: PetVivo Reports Fiscal Q2 2026 Results With Revenues Up 50%

11.1.5 Nov 06, 2025: Paho Promotes Interregional Cooperation to Strengthen Health Autonomy in Latin America and the Caribbean

11.1.6 Oct 30, 2025: Regenerative Treatments: PRP, Stem Cell, Exosome, and Hyaluronic Acid

11.1.7 Oct 28, 2025: Alira Health Advises Andera Partners On Strategic Investment In Adler Ortho

11.1.8 Oct 23, 2025: Integrum Announces Organizational Restructuring to Strengthen Its Commercial Focus

11.1.9 Oct 07, 2025: Allegro Demonstrates Injectable Hydrogel's Shock-Absorbing Capacity for Osteoarthritis

11.1.10 Oct 07, 2025: Bip Proof Programme Funds Innovative I3S Projects

11.1.11 Oct 03, 2025: Manufacturer Of Biodegradable Implants Secures 30 Million Rubles From Moscow Venture Fund And Global Market Access

11.1.12 Oct 02, 2025: Gimv Invests CHF 28 Million in Spineart

11.1.13 Sep 16, 2025: MUDr. Martin Kloub Appointed Associate Professor for Surgical Atlas

11.1.14 Aug 19, 2025: Medtronic Appoints John Groetelaars and Bill Jellison as Independent Directors

11.1.15 Jul 08, 2025: Medtronic Appoints Chad Spooner as Chief Financial Officer of MiniMed

11.1.16 May 21, 2025: Medtronic Announces Leadership Change in Cardiovascular Portfolio

11.2 Financial Announcements

11.2.1 Nov 14, 2025: PetVivo Reports Fiscal Q2 2026 Results With Revenues Up 50%

11.2.2 May 07, 2025: Medtronic to Announce Financial Results for Its Fourth Quarter and Full Fiscal Year 2025

11.3 Government and Public Interest

11.3.1 Sep 05, 2025: 107th Meeting of the Economic Council of CIS Held in Dushanbe

11.3.2 Sep 02, 2025: Ocugen to Participate in H.C. Wainwright 27th Annual Global Investment Conference & Biotech on Tap 2025

11.3.3 Aug 29, 2025: Medtronic Executives to Speak at Upcoming Investor Conferences

11.3.4 May 23, 2025: Medtronic Chairman and CEO Geoff Martha to Speak at Bernstein's Strategic Decisions Conference

11.4 Other Significant Developments

11.4.1 Nov 19, 2025: LEM Surgical Completes First U.S. Clinical Procedures

11.4.2 Oct 28, 2025: Aap Implantate AG Reports Strong Q3 Growth

11.4.3 Oct 23, 2025: Integrum Announces Organizational Restructuring to Strengthen Its Commercial Focus

11.4.4 Oct 17, 2025: University Hospital Vienna And MedUni Vienna Choose Innovative TAPE Method

11.4.5 Oct 03, 2025: Manufacturer Of Biodegradable Implants Secures 30 Million Rubles From Moscow Venture Fund And Global Market Access

11.5 Product News

11.5.1 Nov 19, 2025: LEM Surgical Completes First U.S. Clinical Procedures

11.5.2 Nov 14, 2025: PetVivo Reports Fiscal Q2 2026 Results With Revenues Up 50%

11.5.3 Nov 13, 2025: Implanet Signs Partnership Agreement With 8i Robotics Inc. For Clinical Evaluation Of Robotic Spine Surgery System

11.5.4 Nov 13, 2025: Icotec Receives FDA Clearance for CMORE CT System, Expanding BlackArmor Engineered Carbon/PEEK Technology

11.5.5 Oct 29, 2025: Joint Replacement: AOK Rheinland-Pfalz/Saarland Partners with ActiveTEP

11.5.6 Oct 27, 2025: Mineral Nanotube Coating Extends Lifespan of Biodegradable Implants

11.5.7 Oct 23, 2025: ABRYSVO Receives Expanded Public Funding Across Canadian Provinces for 2025-2026 RSV Season

11.5.8 Oct 20, 2025: Biedermann Motech Expands MOSS!MODULARITY Platform with New Product Introductions

11.5.9 Oct 07, 2025: Allegro Demonstrates Injectable Hydrogel's Shock-Absorbing Capacity for Osteoarthritis

11.5.10 Oct 07, 2025: Bip Proof Programme Funds Innovative I3S Projects

11.5.11 Oct 01, 2025: Bioretec's RemeOs Screw LAG Solid Receives CMS Transitional Pass-Through Payment

11.5.12 Oct 01, 2025: FDA Grants Clearance For Planmed XFI Full-Body Weight-Bearing CT Scanner

11.5.13 Sep 18, 2025: Brainlab Secures FDA 510(k) Clearance and Launches Spine Mixed Reality Navigation

11.5.14 Sep 17, 2025: First Touch CMC 1 Prosthesis Implanted in the United States

11.5.15 Sep 16, 2025: HM Málaga First Private Hospital In Andalusia To Use 3D Spine Surgery Navigator

11.5.16 Sep 15, 2025: Bonesupport Holding AB (publ): Strong CERAMENT Results Presented

11.5.17 Sep 12, 2025: Bioretec Provides Update on RemeOs DrillPin Commercialization

11.6 Research And Development

11.6.1 Oct 27, 2025: Mineral Nanotube Coating Extends Lifespan of Biodegradable Implants

11.6.2 Oct 07, 2025: Bip Proof Programme Funds Innovative I3S Projects

11.7 Strategy And Business Planning

11.7.1 Nov 14, 2025: PetVivo Reports Fiscal Q2 2026 Results With Revenues Up 50%

11.7.2 Nov 03, 2025: LISI Group Confirms Sale of LISI MEDICAL Division to SK Capital

11.7.3 Oct 29, 2025: Joint Replacement: AOK Rheinland-Pfalz/Saarland Partners with ActiveTEP

11.7.4 Oct 28, 2025: Alira Health Advises Andera Partners On Strategic Investment In Adler Ortho

11.7.5 Oct 28, 2025: Scoliosis Research Society Forms New Partnership with EUROSPINE

11.7.6 Oct 21, 2025: Uel And Mbst Collaborate On Health Research

11.7.7 Oct 20, 2025: Biedermann Motech Expands MOSS!MODULARITY Platform with New Product Introductions

11.7.8 Oct 02, 2025: Gimv Invests CHF 28 Million in Spineart

11.7.9 Sep 17, 2025: Keensight Capital Acquires Majority Stake in Isto Biologics from Thompson Street Capital Partners

11.7.10 Sep 16, 2025: HM Málaga First Private Hospital In Andalusia To Use 3D Spine Surgery Navigator

12 Appendix

12.1 Research Methodology

12.1.1 Coverage

12.1.2 Secondary Research

12.1.3 Primary Research

12.1.4 Market Modeling and Forecasting

12.1.5 Company Share Analysis

12.1.6 Benchmarking

12.2 GlobalData Consulting

12.3 Contact Us

12.4 Disclaimer

Table

Table 1: Orthobiologics Market, Cross Country Comparison, EU5, Revenue ($m), USD Constant, 2018-2033

Table 2: Orthobiologics Market, EU5, Revenue ($m), USD Constant, 2018-2033

Table 3: Orthobiologics Market, EU5, Volume (Units), 2018-2033

Table 4: Orthobiologics Market, EU5, Volume (Units), 2018-2033

Table 5: Orthobiologics Market, EU5, Company Share by Revenue ($m), 2025

Table 6: Orthobiologics Market, France, Revenue ($m), USD Constant, 2018-2033

Table 7: Bone Grafts and Substitutes Market, France, Revenue ($m), USD Constant, 2018-2033

Table 8: Bone Growth Stimulators Market, France, Revenue ($m), USD Constant, 2018-2033

Table 9: Cartilage Repair Market, France, Revenue ($m), USD Constant, 2018-2033

Table 10: Soft Tissue Biologics Market, France, Revenue ($m), USD Constant, 2018-2033

Table 11: Viscosupplementation Market, France, Revenue ($m), USD Constant, 2018-2033

Table 12: Orthobiologics Market, France, Volume (Units), 2018-2033

Table 13: Bone Grafts and Substitutes Market, France, Volume (Units), 2018-2033

Table 14: Bone Growth Stimulators Market, France, Volume (Units), 2018-2033

Table 15: Cartilage Repair Market, France, Volume (Units), 2018-2033

Table 16: Soft Tissue Biologics Market, France, Volume (Units), 2018-2033

Table 17: Viscosupplementation Market, France, Volume (Units), 2018-2033

Table 18: Orthobiologics Market, France, Average Price ($), 2018-2033

Table 19: Orthobiologics Market, France, Company Share by Revenue ($m), 2025

Table 20: Orthobiologics Market, Germany, Revenue ($m), USD Constant, 2018-2033

Table 21: Bone Grafts and Substitutes Market, Germany, Revenue ($m), USD Constant, 2018-2033

Table 22: Bone Growth Stimulators Market, Germany, Revenue ($m), USD Constant, 2018-2033

Table 23: Cartilage Repair Market, Germany, Revenue ($m), USD Constant, 2018-2033

Table 24: Soft Tissue Biologics Market, Germany, Revenue ($m), USD Constant, 2018-2033

Table 25: Viscosupplementation Market, Germany, Revenue ($m), USD Constant, 2018-2033

Table 26: Orthobiologics Market, Germany, Volume (Units), 2018-2033

Table 27: Bone Grafts and Substitutes Market, Germany, Volume (Units), 2018-2033

Table 28: Bone Growth Stimulators Market, Germany, Volume (Units), 2018-2033

Table 29: Cartilage Repair Market, Germany, Volume (Units), 2018-2033

Table 30: Soft Tissue Biologics Market, Germany, Volume (Units), 2018-2033

Table 31: Viscosupplementation Market, Germany, Volume (Units), 2018-2033

Table 32: Orthobiologics Market, Germany, Average Price ($), 2018-2033

Table 33: Orthobiologics Market, Germany, Company Share by Revenue ($m), 2025

Table 34: Orthobiologics Market, Italy, Revenue ($m), USD Constant, 2018-2033

Table 35: Bone Grafts and Substitutes Market, Italy, Revenue ($m), USD Constant, 2018-2033

Table 36: Bone Growth Stimulators Market, Italy, Revenue ($m), USD Constant, 2018-2033

Table 37: Cartilage Repair Market, Italy, Revenue ($m), USD Constant, 2018-2033

Table 38: Soft Tissue Biologics Market, Italy, Revenue ($m), USD Constant, 2018-2033

Table 39: Viscosupplementation Market, Italy, Revenue ($m), USD Constant, 2018-2033

Table 40: Orthobiologics Market, Italy, Volume (Units), 2018-2033

Table 41: Bone Grafts and Substitutes Market, Italy, Volume (Units), 2018-2033

Table 42: Bone Growth Stimulators Market, Italy, Volume (Units), 2018-2033

Table 43: Cartilage Repair Market, Italy, Volume (Units), 2018-2033

Table 44: Soft Tissue Biologics Market, Italy, Volume (Units), 2018-2033

Table 45: Viscosupplementation Market, Italy, Volume (Units), 2018-2033

Table 46: Orthobiologics Market, Italy, Average Price ($), 2018-2033

Table 47: Orthobiologics Market, Italy, Company Share by Revenue ($m), 2025

Table 48: Orthobiologics Market, Spain, Revenue ($m), USD Constant, 2018-2033

Table 49: Bone Grafts and Substitutes Market, Spain, Revenue ($m), USD Constant, 2018-2033

Table 50: Bone Growth Stimulators Market, Spain, Revenue ($m), USD Constant, 2018-2033

Table 51: Cartilage Repair Market, Spain, Revenue ($m), USD Constant, 2018-2033

Table 52: Soft Tissue Biologics Market, Spain, Revenue ($m), USD Constant, 2018-2033

Table 53: Viscosupplementation Market, Spain, Revenue ($m), USD Constant, 2018-2033

Table 54: Orthobiologics Market, Spain, Volume (Units), 2018-2033

Table 55: Bone Grafts and Substitutes Market, Spain, Volume (Units), 2018-2033

Table 56: Bone Growth Stimulators Market, Spain, Volume (Units), 2018-2033

Table 57: Cartilage Repair Market, Spain, Volume (Units), 2018-2033

Table 58: Soft Tissue Biologics Market, Spain, Volume (Units), 2018-2033

Table 59: Viscosupplementation Market, Spain, Volume (Units), 2018-2033

Table 60: Orthobiologics Market, Spain, Average Price ($), 2018-2033

Table 61: Orthobiologics Market, Spain, Company Share by Revenue ($m), 2025

Table 62: Orthobiologics Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033

Table 63: Bone Grafts and Substitutes Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033

Table 64: Bone Growth Stimulators Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033

Table 65: Cartilage Repair Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033

Table 66: Soft Tissue Biologics Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033

Table 67: Viscosupplementation Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033

Table 68: Orthobiologics Market, United Kingdom, Volume (Units), 2018-2033

Table 69: Bone Grafts and Substitutes Market, United Kingdom, Volume (Units), 2018-2033

Table 70: Bone Growth Stimulators Market, United Kingdom, Volume (Units), 2018-2033

Table 71: Cartilage Repair Market, United Kingdom, Volume (Units), 2018-2033

Table 72: Soft Tissue Biologics Market, United Kingdom, Volume (Units), 2018-2033

Table 73: Viscosupplementation Market, United Kingdom, Volume (Units), 2018-2033

Table 74: Orthobiologics Market, United Kingdom, Average Price ($), 2018-2033

Table 75: Orthobiologics Market, United Kingdom, Company Share by Revenue ($m), 2025

Table 76: Orthobiologics Market Pipeline Products

Table 77: Total Number of Primary Research Participants, Orthopedic Devices Market, by Country

Figures

Figure 1: Orthobiologics Market, Cross Country Comparison, EU5, Revenue ($m), USD Constant, 2018-2033

Figure 2: Orthobiologics Market, EU5, Revenue ($m), USD Constant, 2018-2033

Figure 3: Orthobiologics Market, EU5, Volume (Units), 2018-2033

Figure 4: Orthobiologics Market, EU5, Volume (Units), 2018-2033

Figure 5: Orthobiologics Market, EU5, Company Share (%), 2025

Figure 6: Orthobiologics Market, France, Revenue ($m), USD Constant, 2018-2033

Figure 7: Bone Grafts and Substitutes Market, France, Revenue ($m), USD Constant, 2018-2033

Figure 8: Bone Growth Stimulators Market, France, Revenue ($m), USD Constant, 2018-2033

Figure 9: Cartilage Repair Market, France, Revenue ($m), USD Constant, 2018-2033

Figure 10: Soft Tissue Biologics Market, France, Revenue ($m), USD Constant, 2018-2033

Figure 11: Viscosupplementation Market, France, Revenue ($m), USD Constant, 2018-2033

Figure 12: Orthobiologics Market, France, Volume (Units), 2018-2033

Figure 13: Bone Grafts and Substitutes Market, France, Volume (Units), 2018-2033

Figure 14: Bone Growth Stimulators Market, France, Volume (Units), 2018-2033

Figure 15: Cartilage Repair Market, France, Volume (Units), 2018-2033

Figure 16: Soft Tissue Biologics Market, France, Volume (Units), 2018-2033

Figure 17: Viscosupplementation Market, France, Volume (Units), 2018-2033

Figure 18: Orthobiologics Market, France, Company Share (%), 2025

Figure 19: Orthobiologics Market, Germany, Revenue ($m), USD Constant, 2018-2033

Figure 20: Bone Grafts and Substitutes Market, Germany, Revenue ($m), USD Constant, 2018-2033

Figure 21: Bone Growth Stimulators Market, Germany, Revenue ($m), USD Constant, 2018-2033

Figure 22: Cartilage Repair Market, Germany, Revenue ($m), USD Constant, 2018-2033

Figure 23: Soft Tissue Biologics Market, Germany, Revenue ($m), USD Constant, 2018-2033

Figure 24: Viscosupplementation Market, Germany, Revenue ($m), USD Constant, 2018-2033

Figure 25: Orthobiologics Market, Germany, Volume (Units), 2018-2033

Figure 26: Bone Grafts and Substitutes Market, Germany, Volume (Units), 2018-2033

Figure 27: Bone Growth Stimulators Market, Germany, Volume (Units), 2018-2033

Figure 28: Cartilage Repair Market, Germany, Volume (Units), 2018-2033

Figure 29: Soft Tissue Biologics Market, Germany, Volume (Units), 2018-2033

Figure 30: Viscosupplementation Market, Germany, Volume (Units), 2018-2033

Figure 31: Orthobiologics Market, Germany, Company Share (%), 2025

Figure 32: Orthobiologics Market, Italy, Revenue ($m), USD Constant, 2018-2033

Figure 33: Bone Grafts and Substitutes Market, Italy, Revenue ($m), USD Constant, 2018-2033

Figure 34: Bone Growth Stimulators Market, Italy, Revenue ($m), USD Constant, 2018-2033

Figure 35: Cartilage Repair Market, Italy, Revenue ($m), USD Constant, 2018-2033

Figure 36: Soft Tissue Biologics Market, Italy, Revenue ($m), USD Constant, 2018-2033

Figure 37: Viscosupplementation Market, Italy, Revenue ($m), USD Constant, 2018-2033

Figure 38: Orthobiologics Market, Italy, Volume (Units), 2018-2033

Figure 39: Bone Grafts and Substitutes Market, Italy, Volume (Units), 2018-2033

Figure 40: Bone Growth Stimulators Market, Italy, Volume (Units), 2018-2033

Figure 41: Cartilage Repair Market, Italy, Volume (Units), 2018-2033

Figure 42: Soft Tissue Biologics Market, Italy, Volume (Units), 2018-2033

Figure 43: Viscosupplementation Market, Italy, Volume (Units), 2018-2033

Figure 44: Orthobiologics Market, Italy, Company Share (%), 2025

Figure 45: Orthobiologics Market, Spain, Revenue ($m), USD Constant, 2018-2033

Figure 46: Bone Grafts and Substitutes Market, Spain, Revenue ($m), USD Constant, 2018-2033

Figure 47: Bone Growth Stimulators Market, Spain, Revenue ($m), USD Constant, 2018-2033

Figure 48: Cartilage Repair Market, Spain, Revenue ($m), USD Constant, 2018-2033

Figure 49: Soft Tissue Biologics Market, Spain, Revenue ($m), USD Constant, 2018-2033

Figure 50: Viscosupplementation Market, Spain, Revenue ($m), USD Constant, 2018-2033

Figure 51: Orthobiologics Market, Spain, Volume (Units), 2018-2033

Figure 52: Bone Grafts and Substitutes Market, Spain, Volume (Units), 2018-2033

Figure 53: Bone Growth Stimulators Market, Spain, Volume (Units), 2018-2033

Figure 54: Cartilage Repair Market, Spain, Volume (Units), 2018-2033

Figure 55: Soft Tissue Biologics Market, Spain, Volume (Units), 2018-2033

Figure 56: Viscosupplementation Market, Spain, Volume (Units), 2018-2033

Figure 57: Orthobiologics Market, Spain, Company Share (%), 2025

Figure 58: Orthobiologics Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033

Figure 59: Bone Grafts and Substitutes Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033

Figure 60: Bone Growth Stimulators Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033

Figure 61: Cartilage Repair Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033

Figure 62: Soft Tissue Biologics Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033

Figure 63: Viscosupplementation Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033

Figure 64: Orthobiologics Market, United Kingdom, Volume (Units), 2018-2033

Figure 65: Bone Grafts and Substitutes Market, United Kingdom, Volume (Units), 2018-2033

Figure 66: Bone Growth Stimulators Market, United Kingdom, Volume (Units), 2018-2033

Figure 67: Cartilage Repair Market, United Kingdom, Volume (Units), 2018-2033

Figure 68: Soft Tissue Biologics Market, United Kingdom, Volume (Units), 2018-2033

Figure 69: Viscosupplementation Market, United Kingdom, Volume (Units), 2018-2033

Figure 70: Orthobiologics Market, United Kingdom, Company Share (%), 2025

EU5 Orthobiologics Market Outlook to 2033 – Cartilage Repair, Bone Grafts and Substitutes, Bone Growth Stimulators, Soft Tissue Biologics and Viscosupplementation standard reports
Currency USD
$5,995

Can be used by individual purchaser only

Most Popular
$11,990

Can be shared by unlimited users within one corporate location e.g. a regional office

$17,985

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Add to Basket

Undecided about purchasing this report?

Enquire Before Buying

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

 Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

 Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

 Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

 Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

 Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

 Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

 Senior Account Manager, TSYS

Related reports

View more Orthopedic Devices reports
Medical Devices
New
Clostridium Difficile Tests Market Size by Segments, Share, Regulatory, Reimbursement,…
$7,500 | May 2026
Medical Devices
New
Cholesterol Tests Market Size by Segments, Share, Regulatory, Reimbursement, and…
$7,500 | May 2026
Medical Devices
New
Hepatitis B Tests Market Size by Segments, Share, Regulatory, Reimbursement,…
$7,500 | May 2026
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at EU5 Orthobiologics Market Outlook to 2033 – Cartilage Repair, Bone Grafts and Substitutes, Bone Growth Stimulators, Soft Tissue Biologics and Viscosupplementation in real time.

  • Access a live EU5 Orthobiologics Market Outlook to 2033 – Cartilage Repair, Bone Grafts and Substitutes, Bone Growth Stimulators, Soft Tissue Biologics and Viscosupplementation dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.
Tell me more